Objective: The aim of this study was to assess the impact of personalized prehabilitation on
postoperative complications in high-risk patients undergoing elective major abdominal …

A pulmonary hypertension (PH) registry (Spanish Registry of Pulmonary Arterial Hypertension)
was undertaken to analyse prevalence, incidence and survival of pulmonary arterial …

Rationale: Sildenafil, a phosphodiesterase-5 inhibitor, could be useful for treating
pulmonary hypertension (PH) in chronic obstructive pulmonary disease (COPD). However, …

Feeding problems are frequently encountered in the neonatal intensive care unit as a result
of the survival of greater numbers of preterm, medically fragile, and chronically ill infants. …

Previous studies have reported mortality rates of up to 56% associated with pregnancy in
pulmonary arterial hypertension (PAH) but the management of this disease has changed …

Pulmonary hypertension is a serious complication of chronic obstructive pulmonary disease
(COPD) that currently has no established pharmacological treatment. This study aimed to …

Pulmonary hypertension (PH) is an important complication in the natural history of chronic
obstructive pulmonary disease (COPD). Its presence is associated with reduced survival and …

Objectives of this European Respiratory Society task force were to summarise current studies,
to develop strategies for future research and to increase availability and awareness of …

… In a randomized, placebo-controlled study, Blanco et al (42) evaluated the effects of 3
months’ … Barbera JA, Blanco I. Pulmonary hypertension in patients with chronic obstructive …

Chronic thromboembolic pulmonary hypertension (CTEPH) and idiopathic pulmonary
hypertension (IPAH) share a similar clinical presentation, and a differential diagnosis requires a …